Merck Sharp & Dohme Files IPR Petition on Genentech’s Cabilly Patent

Goodwin
Contact
LinkedIn
Facebook
X
Send
Embed

On October 11, 2016, Merck Sharp & Dohme (MSD) filed for IPR on U.S. Patent No. 6,331,415, one of the Cabilly patents owned by Genentech.  IPR2017-00047.  MSD also filed a motion for joinder with Mylan’s petition for IPR on this patent (IPR2016-00710), representing that its petition is based on grounds identical to those that form the basis for Mylan’s IPR.  MSD’s petition and other important IPR documents on biologic patents are posted on our IPR tracker page.

Send Print Report

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Goodwin | Attorney Advertising

Written by:

Goodwin
Goodwin
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

Goodwin on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign Up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide